Ceryl Tan

Ceryl Tan, PhD, is a versatile professional focused on improving patient outcomes in the healthcare industry. Currently serving as an Analytics Senior Manager in Oncology at AstraZeneca, Ceryl has experience as a consultant at IQVIA and 180 Degrees Consulting, where they facilitated market access strategies and conducted comprehensive analyses. Ceryl co-founded LifeScreen to develop a prognostic test aimed at predicting age-associated diseases. With a solid academic background, including a PhD in Molecular Genetics from the University of Toronto, Ceryl has also contributed to the field as an academic editor and doctoral researcher.